Click on the protein name for more information about the protein.
The Score column is the predicted score of interaction between the two proteins
Click on the Evidence link to view a breakdown of the information about the predicted interaction.
| Key | |
|---|---|
| Module Score | Databases |
![]() | Where interaction is observed in another database a link is provided: |
| Protein 1 (?) | Protein 2 (?) | Name of Protein 2 | Module Scores (?) | Scores (?) | Evidence (?) | Database (?) | |||
|---|---|---|---|---|---|---|---|---|---|
![]() | ![]() | ![]() | ![]() | ||||||
| DOK1 | JAK2 | JAK2: Tyrosine-protein kinase JAK2 | 105.0 | Evidence | |||||
| DOK1 | TYK2 | TYK2: Non-receptor tyrosine-protein kinase TYK2 | 91.10 | Evidence | |||||
| DOK1 | STAT5A | STAT5A, STAT5: Signal transducer and activator of transcription 5A | 85.20 | Evidence | |||||
| DOK1 | NCK2 | NCK2: Cytoplasmic protein NCK2 | 71.10 | Evidence |
|
||||
| DOK1 | HCLS1 | HCLS1, HS1: Hematopoietic lineage cell-specific protein | 64.00 | Evidence | |||||
| DOK1 | STAT5B | STAT5B: Signal transducer and activator of transcription 5B | 62.90 | Evidence | |||||
| DOK1 | CSF1R | CSF1R, FMS: Macrophage colony-stimulating factor 1 receptor precursor | 56.20 | Evidence | |||||
| DOK1 | CRKL | CRKL: Crk-like protein | 51.50 | Evidence |
|
||||
| DOK1 | LYN | LYN: Tyrosine-protein kinase Lyn | 46.90 | Evidence |
|
||||
| DOK1 | SH3BP2 | SH3BP2: Uncharacterized protein SH3BP2 | 46.90 | Evidence | |||||
| DOK1 | SYK | SYK: Tyrosine-protein kinase SYK | 44.40 | Evidence | |||||
| DOK1 | CSK | CSK: Tyrosine-protein kinase CSK | 44.40 | Evidence |
|
||||
| DOK1 | HCK | N/A | 42.00 | Evidence |
|
||||
| DOK1 | VAV1 | VAV1, VAV: Proto-oncogene vav | 42.00 | Evidence | |||||
| DOK1 | FGR | FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR | 42.00 | Evidence |
|
||||
| DOK1 | PKN2 | PKN2, PRK2, PRKCL2: Serine/threonine-protein kinase N2 | 38.10 | Evidence | |||||
| DOK1 | LCP2 | LCP2: Lymphocyte cytosolic protein 2 | 37.80 | Evidence | |||||
| DOK1 | BTK | BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK | 33.90 | Evidence | |||||
| DOK1 | WAS | WAS, IMD2: Wiskott-Aldrich syndrome protein | 32.30 | Evidence | |||||
| DOK1 | KHDRBS1 | KHDRBS1, SAM68: KH domain-containing, RNA-binding, signal transduction-associate | 31.20 | Evidence | |||||
| DOK1 | CBLB | CBLB, RNF56, Nbla00127: E3 ubiquitin-protein ligase CBL-B | 31.20 | Evidence | |||||
| DOK1 | ZAP70 | ZAP70: Uncharacterized protein ZAP70 | 31.20 | Evidence | |||||
| DOK1 | SRC | SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src | 27.90 | Evidence |
|
||||
| DOK1 | WASPIP | N/A | 26.00 | Evidence | |||||
| DOK1 | SOS1 | SOS1: Son of sevenless homolog 1 | 23.70 | Evidence | |||||
| DOK1 | CCT2 | CCT2, 99D8.1, CCTB: T-complex protein 1 subunit beta | 23.70 | Evidence | |||||
| DOK1 | NEK6 | NEK6: Serine/threonine-protein kinase Nek6 | 22.90 | Evidence | |||||
| DOK1 | ABI1 | ABI1, SSH3BP1: Abl interactor 1 | 22.90 | Evidence | |||||
| DOK1 | SRPK2 | SRPK2: Serine/threonine-protein kinase SRPK2 | 21.10 | Evidence | |||||
| DOK1 | KIT | KIT: Mast/stem cell growth factor receptor precursor | 20.50 | Evidence |
|
||||
| DOK1 | NEDD9 | NEDD9, CASL: Enhancer of filamentation 1 | 20.50 | Evidence | |||||
| DOK1 | FYN | FYN: Proto-oncogene tyrosine-protein kinase Fyn | 20.50 | Evidence |
|
||||
| DOK1 | LIMS1 | N/A | 19.90 | Evidence | |||||
| DOK1 | ABL1 | ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 | 17.30 | Evidence |
|
||||
| DOK1 | YWHAB | YWHAB: 14-3-3 protein beta/alpha | 17.10 | Evidence | |||||
| DOK1 | FABP5 | FABP5: Fatty acid-binding protein, epidermal | 17.10 | Evidence | |||||
| DOK1 | RPS6KA3 | RPS6KA3, ISPK1, RSK2: Ribosomal protein S6 kinase alpha-3 | 15.80 | Evidence | |||||
| DOK1 | FGFR1 | FGFR1, FGFBR, FLG, FLT2: Basic fibroblast growth factor receptor 1 precursor | 15.10 | Evidence | |||||
| DOK1 | AXL | AXL, UFO: Tyrosine-protein kinase receptor UFO precursor | 15.10 | Evidence | |||||
| DOK1 | PTPN6 | PTPN6, HCP, PTP1C: Tyrosine-protein phosphatase non-receptor type 6 | 15.00 | Evidence |
|
||||
| DOK1 | FLT1 | FLT1, FLT, FRT: Vascular endothelial growth factor receptor 1 precursor | 14.60 | Evidence | |||||
| DOK1 | LCK | LCK: Proto-oncogene tyrosine-protein kinase LCK | 13.80 | Evidence |
|
||||
| DOK1 | ATRN | N/A | 13.50 | Evidence | |||||
| DOK1 | PTK2B | PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta | 13.40 | Evidence | |||||
| DOK1 | RASA1 | RASA1, RASA: Ras GTPase-activating protein 1 | 13.40 | Evidence |
|
||||
| DOK1 | PDPK1 | PDPK1, PDK1: 3-phosphoinositide-dependent protein kinase 1 | 13.40 | Evidence | |||||
| DOK1 | PDGFRB | PDGFRB: Beta-type platelet-derived growth factor receptor precursor | 13.20 | Evidence | |||||
| DOK1 | PDGFRA | PDGFRA: Alpha-type platelet-derived growth factor receptor precursor | 13.20 | Evidence | |||||
| DOK1 | APS | SH2B2, APS: SH2B adapter protein 2 | 12.40 | Evidence | |||||
| DOK1 | PTPN2 | PTPN2, PTPT: Tyrosine-protein phosphatase non-receptor type 2 | 11.60 | Evidence | |||||
| DOK1 | EGFR | EGFR, ERBB1: Epidermal growth factor receptor precursor | 11.60 | Evidence | |||||
| DOK1 | EEF1G | EEF1G, EF1G, PRO1608: Elongation factor 1-gamma | 10.60 | Evidence | |||||
| DOK1 | PRKCE | PRKCE, PKCE: Protein kinase C epsilon type | 10.40 | Evidence | |||||
| DOK1 | CBL | CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL | 10.00 | Evidence | |||||
| DOK1 | PIK3R2 | PIK3R2: Phosphatidylinositol 3-kinase regulatory subunit beta | 9.0 | Evidence | |||||
| DOK1 | HNRPK | N/A | 8.74 | Evidence | |||||
| DOK1 | TGFBR1 | TGFBR1: TGF-beta receptor type-1 precursor | 8.7 | Evidence | |||||
| DOK1 | KDR | KDR, FLK1: Vascular endothelial growth factor receptor 2 precursor | 8.19 | Evidence | |||||
| DOK1 | INSR | INSR: Insulin receptor precursor | 8.03 | Evidence |
|
||||
| DOK1 | IGFBP3 | IGFBP3, IBP3: Insulin-like growth factor-binding protein 3 precursor | 7.12 | Evidence | |||||
| DOK1 | KIR3DL1 | N/A | 6.82 | Evidence | |||||
| DOK1 | PSMD11 | PSMD11: 26S proteasome non-ATPase regulatory subunit 11 | 6.45 | Evidence | |||||
| DOK1 | SF3B1 | SF3B1, SAP155: Splicing factor 3B subunit 1 | 6.45 | Evidence | |||||
| DOK1 | BCAR1 | BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 | 6.39 | Evidence | |||||
| DOK1 | CD3E | CD3E, T3E: T-cell surface glycoprotein CD3 epsilon chain precursor | 6.28 | Evidence | |||||
| DOK1 | TAF6 | TAF6, TAF2E, TAFII70: Transcription initiation factor TFIID subunit 6 | 5.28 | Evidence | |||||
| DOK1 | TRAF2 | TRAF2, TRAP3: TNF receptor-associated factor 2 | 5.08 | Evidence | |||||
| DOK1 | WASL | WASL: Neural Wiskott-Aldrich syndrome protein | 5.07 | Evidence | |||||
| DOK1 | GRB10 | N/A | 4.68 | Evidence |
|
||||
| DOK1 | AXIN1 | 3.88 | Evidence | ||||||
| DOK1 | GRAP | GRAP: GRB2-related adapter protein | 3.83 | Evidence | |||||
| DOK1 | MID2 | N/A | 3.70 | Evidence | |||||
| DOK1 | BCR | N/A | 3.47 | Evidence | |||||
| DOK1 | CASP3 | CASP3, CPP32: Caspase-3 precursor | 3.47 | Evidence | |||||
| DOK1 | HIST2H2BE | HIST2H2BE, H2BFQ: Histone H2B type 2-E | 3.20 | Evidence | |||||
| DOK1 | PECAM1 | PECAM1: Platelet endothelial cell adhesion molecule precursor | 2.76 | Evidence | |||||
| DOK1 | FXR2 | FXR2, FMR1L2: Fragile X mental retardation syndrome-related protein 2 | 2.59 | Evidence | |||||
| DOK1 | APBA3 | APBA3, MINT3, X11L2: Amyloid beta A4 precursor protein-binding family A member 3 | 2.33 | Evidence | |||||
| DOK1 | SH2D1A | SH2D1A, DSHP, SAP: SH2 domain-containing protein 1A | 2.24 | Evidence |
|
||||
| DOK1 | WIRE | WIPF2, WICH, PP10631, WIRE: WAS/WASL-interacting protein family member 2 | 1.31 | Evidence | |||||
| DOK1 | INPPL1 | INPPL1, SHIP2: Phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase 2 | 1.29 | Evidence | |||||
| DOK1 | CENTB5 | KIAA1716, CENTB5: Centaurin-beta 5 | 1.13 | Evidence | |||||